Wegovy® (semaglutide) injection 2.4 mg is now indicated to treat adults with metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver ...

Legence Corp. today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to a proposed ...

Amsterdam, 14 August 2025 Fastned, a leading European fast charging company, has reported a 44% year-on-year increase in revenue related to charging in H1 alongside strong growth in renewable energy ...